Search PubMed⌕ Search

Biomedical subjects

V L Willman

Publications and source records attributed to V L Willman.

At least 55 records · Page 3Linked to original sources
PubMed1986

Acute aortic occlusion from aspergillosis in a healthy patient with survival.

Valvular endocarditis caused by Aspergillus is a lethal disease. Only two survivors, both with infections of prosthetic valves, have been reported in the world literature. This report describes a patient with an Aspergillus valvular endocarditis on a native valve with embolization to the right axillary, left iliac, and left popliteal arteries and the distal aorta. Diagnosis was made from a thromboembolectomy specimen. Treatment consisted of removal of the peripheral arterial emboli, mitral valve replacement, and prolonged intravenous infusion of high-dose amphotericin B. The patient presently has the longest survival period of any patient with an Aspergillus infection on a native heart valve. The importance of early diagnosis and aggressive operative management by the vascular surgeon needed to properly treat these patients is emphasized.

Adult↗
PubMed1985

The importance of biventricular failure in patients with postoperative cardiogenic shock.

To evaluate the importance of severe biventricular failure in patients with postcardiotomy ventricular failure, we analyzed the data from 30 patients treated with ventricular assist devices (VADs) over a five-year period. All patients had profound postoperative ventricular failure refractory to drugs and an intraaortic balloon (IAB). Evaluation of preoperative ventricular function did not allow prediction of which patients would require VADs. However, the development of perioperative myocardial infarction was an important determinant of the need for postoperative support with a VAD. Twenty patients received only a left VAD (LVAD). Four of them had isolated left ventricular failure; 3 were weaned, and 2 survived. None of the 16 patients with biventricular failure who received only an LVAD were weaned. Ten other patients with biventricular failure received biventricular support, either with a right VAD and IAB, or with two VADs. Of these 10 patients, 5 were weaned and 3 survived. Considering all 26 patients with biventricular failure, those receiving biventricular mechanical support (10) had a better chance (p less than 0.025) of being weaned (5/10) and surviving (3/10) than those who received only an LVAD (0/16). We conclude that biventricular failure is common in patients with postcardiotomy ventricular failure and is often the result of perioperative infarction. While patients with isolated left ventricular failure did well with an LVAD only, those with biventricular failure required biventricular mechanical support for survival.

Adolescent↗
PubMed1985

Intraoperative myocardial protection: a comparison of blood and asanguineous cardioplegia.

Cardiac arrest was achieved in 84 patients using asanguineous cardioplegia and in 97 patients using cold blood potassium cardioplegia. The patient groups were similar in age, sex ratio, and preoperative risk factors. Other than the cardioplegic solution used, the conduct of each operation was identical. There were no differences in mean total pump time (118 minutes for the asanguineous cardioplegia group versus 117 minutes for the cold blood cardioplegia group) or cross-clamp time (73.5 versus 70 minutes, respectively). However, the blood cardioplegia group had a greater number of distal anastomoses per patient (3.9 versus 3.7; p less than 0.05). Myocardial protection was assessed clinically and by serial electrocardiograms. Cellular integrity was determined by release of the myocardial isoenzyme of serum creatine kinase (CK-MB). Cellular morphology was studied in 6 randomly selected patients in each group by electron microscopic examination of left ventricular myocardial samples obtained before and after bypass. Three patients given blood cardioplegia and 5 given asanguineous cardioplegia required intraaortic balloon counterpulsation at termination of bypass. There were no ultrastructural changes in either group. Electrocardiographic changes (Minnesota code) occurred in 12 of 84 patients receiving asanguineous cardioplegia versus 12 of 97 patients receiving cold blood potassium cardioplegia. To maintain a satisfactory cardiac index (greater than 2.0 L/min/m2), 38 of 84 patients given asanguineous cardioplegia versus 25 of 97 patients given blood cardioplegia required inotropic support up to 24 hours postoperatively (p less than 0.05). Infarct size determined from CK-MB release was significantly greater (p less than 0.05) in patients given asanguineous cardioplegia (36.27 gm-equivalents) than in those given blood cardioplegia (26.7 gm-equivalents).(ABSTRACT TRUNCATED AT 250 WORDS)

Blood Transfusion↗
PubMed1984

Global left ventricular impairment and myocardial revascularization: determinants of survival.

Of 2,782 patients undergoing isolated coronary artery bypass grafting (CABG) from 1970 through 1979, 196 exhibited severe global impairment of left ventricular (LV) wall motion preoperatively (LV score, greater than or equal to 15; ejection fraction, less than 0.40 in all patients and less than 0.30 in 67%). The initial 89 patients (Group 1) underwent CABG without potassium chloride cardioplegia. The subsequent 107 patients (Group 2) were given potassium chloride cardioplegia intraoperatively. Group B patients received more grafts per patient (3.1 versus 2.5; p less than 0.001) and were completely revascularized more often (72.9% versus 58.4%; p less than 0.05). Operative mortality was lower in Group B (3.7% versus 12.4%; p less than 0.025), and 5-year cumulative survival was better in Group B (88.8% versus 63.9%; p less than 0.0001). Preoperative congestive heart failure resulted in higher operative mortality (14.3% versus 4.5%; p less than 0.05) and lower 5-year survival (65.0% versus 81.8%; p less than 0.02). Complete revascularization led to higher 5-year survival (82.2% versus 66.0%; p less than 0.02) but did not alter operative mortality significantly (6.9% versus 9.1%). Potassium chloride cardioplegia may influence operative survival favorably by reducing perioperative myocardial infarction in patients with severe LV dysfunction. Long-term survival relates to completeness of revascularization and severity of congestive heart failure as variables independent of methods of myocardial protection.

Coronary Artery Bypass↗
PubMed1982

Coronary artery stenosis following aortic valve replacement and intermittent intracoronary cardioplegia.

From July, 1977, to July, 1980, intermittent cold blood potassium cardioplegia was used in 208 patients undergoing aortic valve replacement. Aortic root injection of the cardioplegic solution at 10 degrees C was followed every 20 to 30 minutes by infusions of the solution through Silastic cannulas sutured in the coronary orifices or reinserted with each injection. Symptoms of myocardial ischemia developed in 6 patients 3 to 30 months postoperatively. Coronary angiography confirmed new stenoses of the left orifice (3 patients), left main trunk (1 patient), left anterior descending coronary artery (2 patients), circumflex coronary artery (1 patients), and right orifice (3 patients). Four patients underwent saphenous vein grafting procedures, with 2 deaths; 2 patients refused reoperation. A seventh patient with 80% stenosis of the circumflex coronary artery and a posterolateral myocardial infarction died 2 months after double-valve replacement. Intermittent cold blood potassium cardioplegia instead of continuous perfusion did not prevent coronary arterial injury. Injuries occurred in the distal coronary arteries as well as the orifices and were not prevented by withdrawal of the cannulas between injections. Tight-fitting cannulas and high-pressure injection should be avoided. A careful search for coronary arterial injury should be made in all symptomatic patients following aortic valve replacement.

Adult↗
PubMed1982

Management of the patient with coronary artery disease. A surgeon's perspective.

The patient who has symptomatic coronary artery disease suffers from a chronic, incurable illness. The physician must help such a patient adapt to the disease. Coronary artery bypass surgery is, in many instances, a valuable therapeutic adjunct that provides both physiologic and psychologic benefit. It frees many patients from angina pectoris and, in some instances, prolongs life. It often gives the patient the confidence of knowing that maximum effort is being expended to combat the disease. Selectively used, coronary artery bypass is an effective component in the total management of patients with coronary artery disease.

Activities of Daily Living↗
PubMed1981

Continuous hydralazine infusion for afterload reduction.

Impedance reduction with a continuous infusion of hydralazine was evaluated in 20 patients following cardiopulmonary bypass. Patients were selected for therapy when the cardiac index (CI) was less than 2.2 L/m2/min, when the systemic vascular resistance index (SVRI) was greater than 2,500 dyne sec cm-5, or when both conditions were present. No other vasoactive or cardiotonic drugs were used intraoperatively or postoperatively. Responses were measured at 15, 30, 60, 120, 180, and 240 minutes and compared with control measurements. Significant responses appeared by 15 minutes in the mean arterial pressure, CI, and SVRI, which were maximal by 2 hours. At 4 hours, the SVRI was 1,520 +/- 276 dyne sec cm-5 (control, 3,235 +/- 222) and pulmonary vascular resistance index, 365 +/- 102 dyne sec cm-5 (control, 592 +/- 71). The CI was 3.20 +/- 0.29 L/m2/min (control, 1.96 +/- 0.16) and mean arterial pressure, 75 +/- 2.3 mm Hg (control, 92 +/- 2.4). Left atrial, pulmonary artery diastolic, and right atrial pressures increased from control but not significantly: 11.4 +/- 0.8 to 13.3 +/- 1.2 mm Hg, 13.6 +/- 1.6 to 17.2 +/- 1.5 mm Hg, and 6 +/- 1.6 to 9.4 +/- 1.7 mm Hg, respectively. In 16 patients, hydralazine was continued for 24 hours and in 11, the transition to oral therapy was made. Hydralazine by infusion effectively reduces after load, avoids the fluctuations of bolus therapy, and allows the transition to oral therapy if needed.

Blood Pressure↗
PubMed1981

Glenn shunt: long-term results and current role in congenital heart operations.

Fifty cyanotic patients (aged 2 days to 22 years) underwent Glenn shunts for tricuspid atresia and other cyanotic heart defects. Thirteen of 15 operative deaths occurred in infants less than 4 months old, and only 1 death has occurred in the last 9 years. Results were poor in patients with Ebstein's anomaly, truncus arteriosus, transposition of the great vessels, and complex defects other than tricuspid atresia and univentricular heart. Of the 35 patients followed from 0.9 to 14.8 years, 12 were followed for more than 10 years. None of the 11 late deaths could be attributed to complications of the shunt. Minimal evidence of intrapulmonary shunting was found by angiography, pulmonary venous oximetry, or radioisotopic studies. Late deterioration due to venous collaterals and decreased flow to the opposite lung necessitated Blalock-Taussig shunts in 6 and Fontan procedures in 10. All survived the Fontan procedures with minimal morbidity. These data support the concept that Glenn shunts do not necessarily result in pulmonary abnormalities and may be indicated as a staged procedure in a few selected patients prior to a Fontan procedure.

Adolescent↗
PubMed1981

Left main equivalent: results of medical and surgical therapy.

Stenosis of at least 50% of both the left anterior descending and circumflex coronary arteries proximal to their major branches has sometimes been called left main equivalent (LME) disease. During a 4-year interval, 189 LME patients were identified as surgical candidates by angiographic criteria. Coronary artery bypass grafting (CABG) was performed in 119 patients; 70 patients were managed nonoperatively. Treatment assignment was nonrandom. During the same interval, 203 patients with significant left main coronary artery (LMCA) stenosis and 742 patients with three-vessel disease without LMCA or LME stenosis underwent CABG. Follow-up is 99.2% complete at an average of 48 months (range 24--73 months). Operative mortality was significantly higher among LMCA patients (4.0%) than among LME surgical patients (0.8%) (p less than 0.05). Cumulative 5-year survival was better among LME surgical patients (98.2 +/- 1.3%) than among LME medical patients (75.9 +/- 5.7%) (p less than 0.0001) or LMCA surgical patients (92.8 +/- 2.1%) (p less than 0.03). All operative patient groups had a significantly lower incidence of myocardial infarction (10.3--13.4%) than the LME medical patients (25.7%) (p less than 0.05). Relief of angina was also significantly better in the operative groups (61--67.6%) than in LME medical patients (36%) (p less than 0.005). Major differences exist between LME and LMCA patients; LME is more properly considered a variant of multivessel coronary artery disease. Results of medical and surgical therapy suggest that patients with LME disease should be strongly considered for early operative therapy.

Aged↗
PubMed1980

Nesidioblastosis in children.

Three cases in which seizure disorder was first noticed were examined in the last seven years; low fasting glucose and high serum insulin levels then led to the diagnosis of severe hypoglycemia secondary to nesidioblastosis. Hypoglycemic episodes were uncontrolled by frequent oral feedings and intravenous administration of dextrose, glucagon, and diazoxide. Within three weeks after diagnosis, all three patients underwent subtotal pancreatectomy; all three survived and have been followed-up for two to seven years. Two remain euglycemic and have no evidence of CNS damage. The third has occasional fasting hypoglycemia that is treated with diazoxide; he continues to have a seizure disorder and is mentally retarded. Neonatal hypoglycemia secondary to hyperinsulinism requires prompt recognition and aggressive treatment to avoid irreversible CNS damage. Subtotal pancreatectomy safely and effectively restores the euglycemic state.

Adenoma, Islet Cell↗
PubMed1980

Clinical experience with cold blood as the vehicle for hypothermic potassium cardioplegia.

Intermittent cold ischemic arrest was compared with hypothermic potassium cardioplegia using cold blood as the vehicle in two consecutive series of patients having isolated coronary bypass grafting. Between January 1, 1977, and June 30, 1977, 196 patients were operated on using cold ischemic arrest. The incidence of perioperative infarction was 14.3%, and mean total myocardial ischemia time was 42 +/- 1.2 minutes. From July 1, 1977, to June 30, 1978, there were 428 operations done using cold blood with potassium. The incidence of perioperative infarction was 5.6% (p less than 0.005), and the mean total myocardial ischemic time was 80 +/- 2.1 minutes. In the five years prior to this study, the incidence of perioperative infarction was constant at 13% while operative mortality was declining from 5 to 1% and the need for postoperative myocardial support was declining also. Use of cold blood potassium cardioplegia compared with cold ischemic arrest for myocardial protection during coronary artery operations has significantly reduced the incidence of perioperative infarction while doubling cross-clamp time.

Aspartate Aminotransferases↗
PubMed1980

The rationale for operative therapy of symptomatic single-vessel coronary artery disease.

During an 8 year interval, 184 patients with symptomatic single-vessel disease underwent coronary artery bypass grafting (CABG). There were no operative deaths and only one late cardiac death (5 year cumulative survival 97.9%). At 48 months mean follow-up, 91% are angina free or improved. The low incidence of perioperative and late myocardial infarction (MI) and the preservation of ventricular function seen on follow-up catheterization suggest that coronary bypass operations yield significant benefits in severely symptomatic patients with single-vessel disease. Evidence is presented which supports the idea that single-vessel coronary artery disease may be a unique manifestation of coronary atherosclerosis and not one stage in a continuum.

Angiocardiography↗